Which outcome is improved by antiplatelet medications after MI?

Which outcome is improved by antiplatelet medications after MI?

• A. Survival
• B. Blood glucose
• C. LDL levels
• D. Blood pressure

Answer: (A)

Antiplatelet medications after a myocardial infarction primarily work to prevent further clot formation by inhibiting platelet activation and aggregation. This reduces the likelihood of additional occlusive thrombi in the coronary arteries, which lowers the risk of reinfarction and death, thereby improving survival. These drugs don’t directly affect metabolic or hemodynamic parameters, so they don’t change blood glucose, LDL levels, or blood pressure. Glucose and LDL are managed with diabetes or lipid-lowering therapies, and blood pressure with antihypertensives and lifestyle changes.

Antiplatelet medications after a myocardial infarction primarily work to prevent further clot formation by inhibiting platelet activation and aggregation. This reduces the likelihood of additional occlusive thrombi in the coronary arteries, which lowers the risk of reinfarction and death, thereby improving survival. These drugs don’t directly affect metabolic or hemodynamic parameters, so they don’t change blood glucose, LDL levels, or blood pressure. Glucose and LDL are managed with diabetes or lipid-lowering therapies, and blood pressure with antihypertensives and lifestyle changes.